207
Archives of Cardiovascular Diseases Supplements (2016) 8, 205-207
recorded in relation to: cardiogenic shock (3 cases), asystole occurred following an unreduced by EEC FV (2 cases) and hemorrhagic stroke (1 case).
Aims The aim was to determine the impact of better adherence to antihypertensive agents on patient’s outcomes.
Conclusion Thrombolysis by Tenecteplase of STEMI admitted to ICCU was successfull in 89% of cases, which proves its effectiveness compared with other thrombolytic agents. The reperfusion rate was inversely proportional to time limit chest pain – arrival at ER. Patient education to call the ambulance (190) in case of chest pain should improve this delay and increase the reperfusion rate.
Patients and methods We proceed to prospective study of 57 diabetic’s patients with acute coronary syndrome (ACS), from January to June 2015 in Cardiology department of IBN ROCHD University Hospital of Casablanca (Morocco), after collecting general demographic characteristics, the assessment of adherence to the medical regime was by the Morisky Medication Adherence Scale (MMAS 4 – item version).
The author hereby declares no conflict of interest
0084 Adherence to antihypertensive agents in acute coronary syndrome: Moroccan experience Imad Nouamou *, Kenza Benmallem, Amina Bami, Najoua Fikal,Chaimaa Houari, Ilham Bensahi, Ghali Bennouna, Leila Azzouzi, Rachida Habbal CHU Ibn Rochd, Casablanca, Maroc * Corresponding author:
[email protected] (Imad Nouamou) Introduction Antihypertensive (AH) agents have been shown to reduce the risk of cardiovascular events, including coronary artery disease. Nonadherence to AH agents may reduce their effectiveness.
Results In this period 57 patients with ACS were included (42% of total ACS). The mean patient age was 64±8 years, 43, 9 % were male. Among these patients, level of compliance was 60% according to (MMAS 4). Compared with non compliant patients, lower adherence level was associated with a high risk on in-hospital mortality (p=0,037) and 30-day mortality (p=0,015). Conclusion this study is among the first conducted in Morocco which suggests that better adherence to AH agents is associated with a risk reduction of ACS. Adherence to hypoglycemic agents needs to be improved so that patients can benefit from the full protective effects of hypoglycemic therapies. The author hereby declares no conflict of interest
© Elsevier Masson SAS. All rights reserved.